BioWorld

May 15, 2007

View Archived Issues

Targanta Seeks $86M In IPO For Antibiotic Development

As it prepares to file a new drug application for the antibiotic oritavancin in the first quarter of 2008, Targanta Therapeutics Corp. filed to raise $86.25 million in an initial public offering. (BioWorld Today) Read More

Critical Therapeutics' Shares Rise On Perforomist Approval

Read More

Complementary Approaches Snare New Huntington's Targets

Read More

Neurotech-Focused Parties Come Together Under NIO

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

Clinic Roundup

Read More